LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances

Study limitation reported by the research below: “The post-keratorefractive subgroup (n=25) was analyzed post-hoc and is likely underpowered; findings should be interpreted as hypothesis-generating only.”